Study Conduct

DAC Patient Recruitment continues as Global Impact Partner with SCRS

Wednesday, July 22, 2015 01:56 PM

DAC Patient Recruitment Services, a Dallas-based company focused on patient recruitment and retention for clinical trials, has renewed its commitment to the Society for Clinical Research Sites (SCRS), a global trade organization, as a Global Impact Partner (GIP) for a second term.

More... »


Synexus expansion across Eastern Europe, adds three new clinical trial centers

Wednesday, July 15, 2015 12:11 PM

Synexus continues to expand across Eastern Europe with three new Dedicated Research Centers in Bulgaria, Poland and Romania, bringing the total to nine centers in Eastern Europe and a total network of 25 across Europe and Africa. These new centers will provide the company’s clients in pharma and CROs with an expanding pool of patients.

More... »


Clinical Conductor CTMS releases update

Wednesday, July 15, 2015 11:46 AM

The latest iteration of Clinical Conductor CTMS, created by Rochester, N.Y.-based Bio-Optronics, continues its strategy of providing research organizations with in-depth features and functionality.

More... »

Society for Clinical Research Sites adds Covance as Global Impact Partner

Monday, July 6, 2015 10:25 AM

The Society for Clinical Research Sites (SCRS), a global trade organization dedicated to representing the interests of clinical research sites, has announced a two-year partnership with Laboratory Corporation of America Holdings (LabCorp). Covance Drug Development will participate as a Global Impact Partner (GIP), a relationship designed to facilitate critical dialogue between industry stakeholders and clinical research sites.

More... »

Astrazeneca, University of Cambridge form joint Ph.D., clinical research scholarships

Wednesday, July 1, 2015 10:11 AM

AstraZeneca and the University of Cambridge have formed three new joint schemes to support more than 80 Ph.D. scholarships and eight clinical lectureships over the next five years, spanning translational science, basic and clinical research.

More... »

Claritas Genomics, Genetic Alliance partner on patients’ results sharing

Wednesday, June 24, 2015 10:38 AM

Claritas Genomics, a Cambridge, Mass.-based genetic diagnostic laboratory, and Genetic Alliance, a nonprofit health advocacy organization based in Wash. D.C., announced a partnership to help patients and families find and participate in relevant research opportunities that will advance understanding of individual genetic disorders and development of new therapies.

More... »

FDA, TransCelerate, INC Research to speak at 10th Annual Global Site Solutions Summit

Wednesday, June 24, 2015 10:11 AM

The Society for Clinical Research Sites (SCRS), a global trade organization representing the interests of clinical research sites, has announced an invigorated, solution-driven program for the 10th Annual Global Site Solutions Summit. The Summit will be Oct. 8-11, in Amelia Island, Fla. The annual meeting, which attracts investigators, site executives and industry executives from around the globe, is inclusive of interactive sessions, knowledge and best practice sharing, and networking opportunities, centered around the collaboration-focused theme “Better Together.”

More... »

BIA responds to Jim O’Neill’s review on antimicrobial resistance

Monday, June 22, 2015 09:54 AM

The U.K. Bioindustry Association (BIA) has submitted its initial response to Jim O’Neill’s review on antimicrobial resistance (AMR), focusing on his interim report Securing new drugs for future generations: The antibiotics pipeline, published in May. Steve Bates, CEO of the BIA, put forward the case that any new economic model should be based on an informed stewardship not restrictive stewardship approach.

More... »

U.S. Oncology Research, Cure Forward collaborate

Friday, June 19, 2015 11:32 AM

U.S. Oncology Research, a network of integrated, community-based oncology practices dedicated to advancing high-quality treatments through clinical trials, has inked a collaboration with Cure Forward, a patient activation company. U.S. Oncology Research and Cure Forward will work together to make personalized medicine more accessible and approachable in the community setting, reinforcing the cooperation that exists between physicians and patients through educational resources and improved clinical trial matching.

More... »

Pharmatech launches recruiting solution CureAcess.com, Just-In-Time model

Friday, June 19, 2015 10:47 AM

Pharmatech, a Denver-based oncology CRO, is changing how clinical trials studies enroll cancer patients by offering a patient-centered, on-demand research alternative. Pharmatech helps cancer patients identify the right trial opportunity, then activates that trial at a nearby treatment center using a Just-In-Time delivery model.

More... »

CWWeekly

July 27

AB Science warned about putting study volunteers in danger

FDA, Google unite to detect search-data adverse events

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs